BIIBvsNTRA
Biogen IncvsNatera Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.
Biogen Inc
$187.88
+6.91%
Natera Inc
$201.14
-11.94%
60-day price, rebased to 100
Round-by-round
Valuation upside
+7.40% vs -67.20% to DCF fair value
Balance-sheet strength
Altman Z 3.10 vs 23.91
Fundamental quality
Piotroski 6.00 vs 5.00 (of 9)
Growth + margins
Rule-of-40 23.00 vs 39.20
60-day momentum
+6.64% vs -13.11% price return
Market-cap liquidity
$25.8B vs $28.0B
Verdict
Across6categories,BIIBtakes the edge with3wins to2 (and 1 tie). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.
Backtest a strategy onBIIBorNTRA
Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.